Engaged Capital LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Engaged Capital LLC reported 9 stock positions worth $616.5 million. Its top holding was Evolent Health Class A (EVH) at 18.3% of the portfolio, followed by VF (VFC, 17.3%) and NCR Voyix (VYX, 15.8%). Compared with Q2 2024, it opened 1 new position, sold out of 4, added to 5 and reduced 1. The biggest buy was Portillo's Class A (PTLO, shares +122%) and the biggest sale an exit from Envestnet (ENV).
- Most Recent 13F
- Q2 2026
- Location
- Newport Beach, CA
- CIK
- 0001559771
- Portfolio Value
- $616.5M (Q3 2024)
- SEC Filing
- 0000921895-24-002693 ↗ filed Nov 14, 2024
Holdings Value
Holdings 9 stocks · $616.5M
| EVH Evolent Health Inc. Class A | 18.30% | 3,989,468 | $112.8M | Reduce -3.0% |
| VFC VF Corp. | 17.28% | 5,341,368 | $106.6M | No change |
| VYX NCR Voyix Corp. | 15.78% | 7,171,029 | $97.3M | Add +14.1% |
| NATL NCR Atleos Corp. | 13.92% | 3,008,223 | $85.8M | Add +19.9% |
| PTLO Portillo's Inc. Class A | 13.36% | 6,114,956 | $82.4M | Add +121.5% |
| BRC INC-A | 7.51% | 13,535,560 | $46.3M | Add +5.3% |
| PRAA Pra Group Inc. | 6.18% | 1,703,512 | $38.1M | No change |
| BL Blackline Inc. | 5.45% | 609,713 | $33.6M | New |
| NVRO Nevro LLC filed as NEVRO CORP | 2.21% | 2,442,956 | $13.7M | Add +29.5% |
Portfolio Sells Q2 2024 → Q3 2024
Portfolio Buys Q2 2024 → Q3 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $322.9M | VFC, YETI, GXO, EVH, FRPT |
| Q1 2026 | 8 | $303.4M | VFC, YETI, BL, GXO, CGNX |
| Q4 2025 | 9 | $392.0M | VFC, YETI, BL, GXO, CGNX |
| Q3 2025 | 9 | $407.6M | VFC, YETI, GXO, EVH, CGNX |
| Q2 2025 | 7 | $357.6M | YETI, EVH, VFC, PTLO, GXO |
| Q1 2025 | 9 | $392.2M | VFC, PTLO, GTLS, YETI, EVH |
| Q4 2024 | 8 | $486.4M | VFC, VYX, NATL, EVH, PTLO |
| Q3 2024 | 9 | $616.5M | EVH, VFC, VYX, NATL, PTLO |
| Q2 2024 | 12 | $583.9M | BRC INC-A, EVH, VYX, VFC, NATL |
| Q1 2024 | 11 | $617.1M | EVH, VFC, SHAK, VYX, UPBD |